Zev A. Wainberg

Zev A. Wainberg, MD

Assistant Professor

Hematology/Oncology

University of California, Los Angeles

Los Angeles, California, United States of America

Professor of Medicine and Surgery
Co-Director of GI Oncology
Director, Early Phase Clinical Research Program
Jonsson Comprehensive Cancer Center
UCLA School of Medicine
Los Angeles, California

Explore Activities by Zev A. Wainberg

Title
Format
Credit Type
Credits
Uncovering Safety and Signposts to the Future: AEs With HER2-Targeted ADCs and Future Applications

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.50
Taking a New Path: Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.50
The Lay of the Land: Overview of Biology of HER2 in Genitourinary, Gastrointestinal, and Gynecologic Malignancies

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.25
Redefining the Possibilities for Patients With HER2-positive Gastroesophageal Cancers

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Redefining the Possibilities for Patients With HER2-Positive Gastroesophageal Cancers

Content Format:

Slideset

Credit Type:

--

Credits:

--
Emerging HER2-Targeted Antibody Drug Conjugates in Gastrointestinal Malignancies

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Think Tank on Emerging HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecologic Malignancies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
CCO Think Tank on Emerging HER2-Targeted ADCs: Gastrointestinal Malignancies

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeted Therapies for HER2-Positive Gastrointestinal Cancers: Experts Answer Your Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
HER2-Positive Advanced Gastrointestinal Cancers: Expert Guidance on Leveraging Targeted Agents to Improve Outcomes

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Incorporating Guideline-Recommended HER2 Testing Into GI Cancer Management

Content Format:

Slideset

Credit Type:

--

Credits:

--
Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
ExpressPoints: Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Content Format:

Slideset Download

Credit Type:

--

Credits:

--